Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Integrative Analysis of Single-Cell Transcriptomics and Mendelian Randomization Reveals BTN3A2 as a Common Protective Factor in Behçet’s Disease and Inflammatory Bowel Disease

  • By

  • Qinjin Dai

  • Yuelan Wu

  • Wenbo Geng

  • Mengna Li

  • Wanyun Zhang

  • Yuxian Lai

  • Pei Zhang

  • Chunjiang Zhou

  • Yinuo Wang

  • Qingfeng Cao

  • Xiang Luo

  • Yujie Lai

  • Changwei Huang

  • Peizeng Yang

  • June 24, 2026

Share

Original Source(s)

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

  • by Qinjin Dai, Yuelan Wu, Wenbo Geng, Mengna Li, Wanyun Zhang, Yuxian Lai, Pei Zhang, Chunjiang Zhou, Yinuo Wang, Qingfeng Cao, Xiang Luo, Yujie Lai, Changwei Huang, Peizeng Yang

  • June 24, 2026

Related Content

Efficacy and safety of obinutuzumab in refractory membranous nephropathy: a single-arm meta-analysis

GRAPPA, EULAR Criteria May Identify Complex PsA

Application of newly proposed GRAPPA and EULAR criteria in a longitudinal cohort identified progressively smaller groups of patients with early psoriatic arthritis who experienced persistently worse patient-reported outcomes.

Racial and ethnic disparities in perceived health and barriers to care among adults with hip osteoarthritis: a national analysis of 16,000 + patients from the all of us program